The consumer group Public Citizen is taking its dispute with the US Food and Drug Administration over labeling for dopamine agonist products to court.
In a lawsuit filed 29 April, the group seeks to force agency action on a nearly three-year-old citizen petition...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?